š£ VC round data is live. Check it out!
- Public Comps
- Cube Labs
Cube Labs Valuation Multiples
Discover Cube Labs' revenue and EBITDA valuation multiples and investment history, alongside public comparables like Smart Capital, Banco Actinver, Shareholder Value, FairPlay Properties REIT and more.
Cube Labs Overview
About Cube Labs
Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for theĀ market.
Founded
2013
HQ

Employees
2
Website
Sectors
Financials (FY)
EV
$63M
Valuation Multiples
Start free trialCube Labs Financials
Cube Labs reported last fiscal year revenue of $2M and negative EBITDA of ($391K).
In the same fiscal year, Cube Labs generated $2M in gross profit, ($391K) in EBITDA losses, and had net loss of ($850K).
Cube Labs P&L
In the most recent fiscal year, Cube Labs reported revenue of $2M and EBITDA of ($391K).
Cube Labs is unprofitable as of last fiscal year, with gross margin of 84%, EBITDA margin of (16%), and net margin of (35%).
Financial data powered by Morningstar, Inc.
Cube Labs Stock Performance
Cube Labs has current market cap of $60M, and enterprise value of $63M.
Market Cap Evolution
Cube Labs' stock price is $2.86.
Cube Labs share price decreased by 0.2% in the last 30 days, and increased by 7.8% in the last year.
Cube Labs has an EPS (earnings per share) of $-0.04.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $63M | $60M | -0.1% | -0.2% | - | 7.8% | $-0.04 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialCube Labs Valuation Multiples
Cube Labs trades at 25.7x EV/Revenue multiple, and (161.4x) EV/EBITDA.
Cube Labs Financial Valuation Multiples
As of June 3, 2026, Cube Labs has market cap of $60M and EV of $63M.
Cube Labs has a P/E ratio of (70.3x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Cube Labs Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Cube Labs Margins & Growth Rates
In the most recent fiscal year, Cube Labs reported gross margin of 84%, EBITDA margin of (16%), and net margin of (35%).
Cube Labs Margins
Cube Labs Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Cube Labs Operational KPIs
Cube Labs' revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $1.5M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Cube Labs Competitors
Cube Labs competitors include Smart Capital, Banco Actinver, Shareholder Value, FairPlay Properties REIT, Seafire, Hilbert Group, IPOPEMA Securities, Skogsfond Baltikum, Ceiba Investments and Quest for Growth.
Most Cube Labs public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 65.1x | - | 7.3x | - | |||
| 6.2x | - | 4.4x | - | |||
| 6.6x | - | - | - | |||
| 2.0x | - | 4.8x | - | |||
| 0.8x | 0.7x | 9.2x | 8.0x | |||
| 2.9x | - | (3.1x) | - | |||
| 0.6x | - | 4.5x | - | |||
| 2.7x | - | - | - | |||
This data is available for Pro users. Sign up to see all Cube Labs competitors and their valuation data. Start Free Trial | ||||||
Investments by Cube Labs
Cube Labs has invested in 1 company to date.
Latest investment by Cube Labs was on May 9th 2023. Cube Labs invested in Adamas Biotech in their $100K Strategic investment round (EV/Revenue multiple available to Pro users).
Latest Investments by Cube Labs
| Description | Adamas Biotech formulates nutraceutical products with green tea extracts exhibiting antioxidant, anti-angiogenic, and anti-inflammatory effects for prostate health and intraepithelial neoplasia prevention. Milan-based, the company supplies clinically validated supplements to wellness brands and healthcare providers in Europe. |
| HQ Country | |
| HQ City | Lecce |
| Deal Date | 9 May 2023 |
| Round | Strategic investment |
| Raised | $100K |
| Investors | Cube Labs; Istituto Nazionale Biostrutture e Biosistemi |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Cube Labs investments and their VC round multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Cube Labs
| When was Cube Labs founded? | Cube Labs was founded in 2013. |
| Where is Cube Labs headquartered? | Cube Labs is headquartered in Italy. |
| How many employees does Cube Labs have? | As of today, Cube Labs has over 2 employees. |
| Is Cube Labs publicly listed? | Yes, Cube Labs is a public company listed on Borsa Italiana. |
| What is the stock symbol of Cube Labs? | Cube Labs trades under CUBE ticker. |
| When did Cube Labs go public? | Cube Labs went public in 2023. |
| Who are competitors of Cube Labs? | Cube Labs main competitors include Smart Capital, Banco Actinver, Shareholder Value, FairPlay Properties REIT, Seafire, Hilbert Group, IPOPEMA Securities, Skogsfond Baltikum, Ceiba Investments, Quest for Growth. |
| What is the current market cap of Cube Labs? | Cube Labs' current market cap is $60M. |
| What is the current revenue of Cube Labs? | Cube Labs' last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of Cube Labs? | Current revenue multiple of Cube Labs is 25.7x. |
| Is Cube Labs profitable? | No, Cube Labs is not profitable. |
| How many companies Cube Labs has acquired to date? | Cube Labs hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Cube Labs has invested to date? | As of June 2026, Cube Labs has invested in 1 company. |
| What was the last Cube Labs investment? | On 9th May 2023 Cube Labs invested in Adamas Biotech, participating in a $100K Strategic investment round, alongside Istituto Nazionale Biostrutture e Biosistemi. |
| In what companies Cube Labs invested in? | Cube Labs invested in Adamas Biotech. |
See public comps similar to Cube Labs
Lists including Cube Labs
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
